2025 Survey Report: The State of Workforce Development
This white paper examines four KPIs most impacting timelines and budgets and offers strategies for effective communication and risk mitigation.
Universal
Logins
Logins Use the links below for logging in to Advarra products and service portals. Advarra’s electronic institutional review board (IRB)
2025: Perspectives and Predictions From Advarra Thought Leaders
2024 has been a year of growth and evolution in clinical research. The coming year is expected to be no
How Your Study’s Informed Consent Can Help Simplify Study Startup
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Join a Review Committee
REVIEWS Become a Member Join Advarra’s review teams to contribute your expertise to advancing research. Our committees play a vital
Central Oncology Review
Advarra meets the growing needs of oncology by offering robust human subject protections that cancer research institutions expect.
Contact Us
Contact Us We’re here to help you move research forward—faster. Whether you have a question, need support, or want to
Site-Sponsor Consortium
Site-Sponsor Consortium Building shared industry standards through collaboration The Site-Sponsor Consortium is an invitation-only forum that brings together influential leaders
The Importance of a Large Network of KOLs for DMCs
In the complex landscape of clinical trials, the data monitoring committee (DMC) serves as the cornerstone at the intersection of
HIPAA Compliance Statement
HIPAA Compliance Statement Advarra, Inc. complies with HIPAA (the Health Insurance Portability and Accountability Act) (including the HIPAA Security and
Technology Solutions Security
Data with Enterprise-grade Security Advarra’s Quality and Information Security Management System focuses on ensuring our operations and products remain secure
About Advarra
Our history We may have taken our current shape in 2017, but our story stretches back more than 40 years.